George Farmer
Stock Analyst at Scotiabank
(4.13)
# 515
Out of 4,412 analysts
30
Total ratings
42.86%
Success rate
22.03%
Average return
Main Sectors:
Top Industries:
19 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BMRN BioMarin Pharmaceutical | Maintains: Sector Perform | $83 → $85 | $82.13 | +3.49% | 3 | Apr 25, 2024 | |
SAGE Sage Therapeutics | Maintains: Sector Outperform | $34 → $19 | $14.18 | +33.99% | 2 | Apr 18, 2024 | |
LEGN Legend Biotech | Upgrades: Sector Outperform | $65 | $45.14 | +44.00% | 2 | Apr 17, 2024 | |
ARGX argenx SE | Maintains: Sector Perform | $402 → $408 | $375.29 | +8.72% | 4 | Mar 26, 2024 | |
ABSI Absci | Initiates: Sector Outperform | $13 | $4.78 | +171.97% | 1 | Mar 14, 2024 | |
NAMS NewAmsterdam Pharma Company | Initiates: Sector Outperform | $35 | $21.66 | +61.59% | 2 | Mar 14, 2024 | |
TPST Tempest Therapeutics | Initiates: Sector Outperform | $13 | $3.44 | +277.91% | 2 | Mar 14, 2024 | |
SNDX Syndax Pharmaceuticals | Downgrades: Sector Perform | $36 → $23 | $21.28 | +8.08% | 2 | Jan 31, 2024 | |
ACLX Arcellx | Initiates: Sector Outperform | $66 | $51.11 | +29.13% | 1 | Dec 19, 2023 | |
KURA Kura Oncology | Initiates: Sector Perform | $11 | $20.06 | -47.66% | 1 | Jul 27, 2023 | |
BMEA Biomea Fusion | Initiates: Sector Outperform | $41 | $10.75 | +281.40% | 1 | Jul 27, 2023 | |
BIIB Biogen | Initiates: Sector Outperform | $327 | $215.50 | +51.74% | 1 | Jul 27, 2023 | |
AURA Aura Biosciences | Initiates: Sector Outperform | $23 | $7.50 | +206.67% | 1 | Jul 27, 2023 | |
MRNA Moderna | Downgrades: Market Perform | n/a | $111.62 | - | 1 | Nov 17, 2020 | |
CCCC C4 Therapeutics | Initiates: Outperform | n/a | $6.32 | - | 1 | Oct 27, 2020 | |
IMUX Immunic | Initiates: Outperform | n/a | $1.23 | - | 1 | Jul 20, 2020 | |
BPMC Blueprint Medicines | Upgrades: Outperform | n/a | $93.10 | - | 2 | Mar 17, 2020 | |
EXEL Exelixis | Maintains: Market Perform | n/a | $23.73 | - | 1 | Feb 26, 2020 | |
INCY Incyte | Maintains: Market Perform | n/a | $52.56 | - | 1 | Jan 3, 2020 |
BioMarin Pharmaceutical
Apr 25, 2024
Maintains: Sector Perform
Price Target: $83 → $85
Current: $82.13
Upside: +3.49%
Sage Therapeutics
Apr 18, 2024
Maintains: Sector Outperform
Price Target: $34 → $19
Current: $14.18
Upside: +33.99%
Legend Biotech
Apr 17, 2024
Upgrades: Sector Outperform
Price Target: $65
Current: $45.14
Upside: +44.00%
argenx SE
Mar 26, 2024
Maintains: Sector Perform
Price Target: $402 → $408
Current: $375.29
Upside: +8.72%
Absci
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $4.78
Upside: +171.97%
NewAmsterdam Pharma Company
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $35
Current: $21.66
Upside: +61.59%
Tempest Therapeutics
Mar 14, 2024
Initiates: Sector Outperform
Price Target: $13
Current: $3.44
Upside: +277.91%
Syndax Pharmaceuticals
Jan 31, 2024
Downgrades: Sector Perform
Price Target: $36 → $23
Current: $21.28
Upside: +8.08%
Arcellx
Dec 19, 2023
Initiates: Sector Outperform
Price Target: $66
Current: $51.11
Upside: +29.13%
Kura Oncology
Jul 27, 2023
Initiates: Sector Perform
Price Target: $11
Current: $20.06
Upside: -47.66%
Biomea Fusion
Jul 27, 2023
Initiates: Sector Outperform
Price Target: $41
Current: $10.75
Upside: +281.40%
Biogen
Jul 27, 2023
Initiates: Sector Outperform
Price Target: $327
Current: $215.50
Upside: +51.74%
Aura Biosciences
Jul 27, 2023
Initiates: Sector Outperform
Price Target: $23
Current: $7.50
Upside: +206.67%
Moderna
Nov 17, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $111.62
Upside: -
C4 Therapeutics
Oct 27, 2020
Initiates: Outperform
Price Target: n/a
Current: $6.32
Upside: -
Immunic
Jul 20, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.23
Upside: -
Blueprint Medicines
Mar 17, 2020
Upgrades: Outperform
Price Target: n/a
Current: $93.10
Upside: -
Exelixis
Feb 26, 2020
Maintains: Market Perform
Price Target: n/a
Current: $23.73
Upside: -
Incyte
Jan 3, 2020
Maintains: Market Perform
Price Target: n/a
Current: $52.56
Upside: -